Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
Joel Unruch, General Counsel and Corporate Secretary of Accenture plc (ticker: ACN), reported a non-derivative transaction dated 08/15/2025. The filing shows a grant of 48 Class A ordinary share units (RSUs) at a reported price of $247.57, recorded as acquired under code A and described as an anti-dilution adjustment to previously granted RSU awards to reflect Accenture's payment of a cash dividend. After the reported transaction, Mr. Unruch is shown as beneficially owning 17,699 Class A ordinary shares, held directly. The form is signed on behalf of Mr. Unruch by an attorney-in-fact on 08/18/2025.
Accenture insider reported an award of restricted share units (RSUs) tied to a dividend adjustment. Melissa A. Burgum, Chief Accounting Officer, reported a transaction dated 08/15/2025 showing an RSU grant described as an anti-dilution adjustment to reflect Accenture plc's cash dividend.
The filing shows a price reference of $247.57 and reports 9,407 Class A ordinary shares beneficially owned following the reported transaction. The Form 4 was signed by an attorney-in-fact on 08/18/2025.
Angela Beatty, Accenture plc Chief Leadership & HR Officer, reported a non-derivative acquisition on 08/15/2025. The Form 4 shows an acquisition (A) of 28 Class A ordinary share units at a price of $247.57, and reports 5,277 Class A ordinary shares beneficially owned following the transaction. The filing explains these units were restricted share units (RSUs) granted pursuant to anti-dilution provisions of previously granted RSU awards to reflect Accenture's cash dividend. The Form was signed by an attorney-in-fact on behalf of Beatty on 08/18/2025.
Transaction: On 08/05/2025 Manish Sharma, an officer of Accenture plc (title listed as CEO-The Americas), purchased 73 Class A ordinary shares of Accenture (ACN) at $250.74 per share pursuant to the Accenture Voluntary Equity Investment Program.
Holdings and form details: Following the purchase the reporting person beneficially owned 1,731 Class A ordinary shares (Direct). No derivative securities are reported. The Form 4 was signed by attorney-in-fact Danika Haueisen on 08/06/2025.